Multi-Omics Study Reveals Nc886/vtRNA2-1 as a Positive Regulator of Prostate Cancer Cell Immunity

Noncoding RNA 886 has emerged as a pivotal regulatory RNA with distinct functions across tissues, acting as a regulator of protein activity by directly binding to protein partners. While it is well recognized as a tumor suppressor in prostate cancer, the underlying molecular mechanisms remain elusive. To discover the principal pathways regulated by nc886 in prostate cancer, we used a transcriptomic and proteomic approach analyzing malignant DU145, LNCaP, PC3, and benign RWPE-1 prostate cell line models transiently transfected with in vitro transcribed nc886 or antisense oligonucleotides. Multiomics revelead a significant enrichment of immune system-related pathways across the cell lines, including cytokines and interferon signaling. The interferon response provoked by nc886 was validated by functional assays. The invariability of PKR phosphorylation and NF-κB activity in the gain/loss of nc886 function experiments and the positive regulation of innate immunity suggest a PKR-independent mechanism of nc886 action. Accordingly, the GSEA of the PRAD-TCGA data set revealed immune stimulation as the nc886 most associated node also in the clinical setting. Our study showed that the reduction of nc886 leads to a blunted immune response in prostate cancer.

Authors

Institutions

Publication Details

Journal
Journal of Proteome Research
Published
2024-12-26
DOI
https://doi.org/10.1021/acs.jproteome.4c00521
Citations
3
Primary Topic
Cancer-related molecular mechanisms research
Type
article
Field-Weighted Citation Impact
0.86

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multi-Omics Study Reveals Nc886/vtRNA2-1 as a Positive Regulator of Prostate Cancer Cell Immunity

Ana Julia Fernández-Álvarez, Yong Sun Lee, Stanley K. Liu, Vladimir Ignatchenko et al.
3 citations
Journal of Proteome Research
Cancer-related molecular mechanisms research
0.86
article

Multi-Omics Study Reveals Nc886/vtRNA2-1 as a Positive Regulator of Prostate Cancer Cell Immunity

Ana Julia Fernández-Álvarez, Yong Sun Lee, Stanley K. Liu, Vladimir Ignatchenko, Thomas Kislinger, Rafael Sebastián Fort, Graciela L. Boccaccio, Marı́a Ana Duhagon, Chiara Colantuono, José Roberto Sotelo-Silveira, Beatríz Garat, Carolina Oliveira‐Rizzo, Shahbaz Khan
article en
3 citations

Abstract

Noncoding RNA 886 has emerged as a pivotal regulatory RNA with distinct functions across tissues, acting as a regulator of protein activity by directly binding to protein partners. While it is well recognized as a tumor suppressor in prostate cancer, the underlying molecular mechanisms remain elusive. To discover the principal pathways regulated by nc886 in prostate cancer, we used a transcriptomic and proteomic approach analyzing malignant DU145, LNCaP, PC3, and benign RWPE-1 prostate cell line models transiently transfected with in vitro transcribed nc886 or antisense oligonucleotides. Multiomics revelead a significant enrichment of immune system-related pathways across the cell lines, including cytokines and interferon signaling. The interferon response provoked by nc886 was validated by functional assays. The invariability of PKR phosphorylation and NF-κB activity in the gain/loss of nc886 function experiments and the positive regulation of innate immunity suggest a PKR-independent mechanism of nc886 action. Accordingly, the GSEA of the PRAD-TCGA data set revealed immune stimulation as the nc886 most associated node also in the clinical setting. Our study showed that the reduction of nc886 leads to a blunted immune response in prostate cancer.

Journal of Proteome ResearchVol. 24(2)
Sunnybrook Health Science Centre (CA), Consejo Nacional de Investigaciones Científicas y Técnicas (AR), Universidad de la República de Uruguay (UY), University of Toronto (CA), Universidad de Buenos Aires (AR), Fundación Instituto Leloir (AR), Princess Margaret Cancer Centre (CA), National Cancer Center (US), National Cancer Center (KR), Instituto de Investigaciones Biológicas Clemente Estable (UY), Fundación Ciencias Exactas y Naturales (AR)
Agencia Nacional de Investigación e Innovación, Universidad de la República Uruguay, Comisión Sectorial de Investigación Científica
Good health and well-being
Openalex Percentile: Top 24%
Cancer-related molecular mechanisms research
0.86
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.